World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
52373
World Ranking
4911
National Ranking
2660

Overview

Corey Cutler is affiliated with Harvard University in the United States and has an extensive publication record primarily in the field of medicine, with a strong focus on hematology. Their research contributions span a variety of subfields including oncology, genetics, public health, environmental and occupational health, and immunology.

The main topics of Cutler's work include:

  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Immune Cell Function and Interaction
  • Childhood Cancer Survivors' Quality of Life
  • Renal Transplantation Outcomes and Treatments

Corey Cutler has published extensively in high-impact venues, with frequent publications in:

  • Transplantation and Cellular Therapy
  • Blood
  • Blood Advances
  • Bone Marrow Transplantation
  • Haematologica

Recent significant papers authored or co-authored by Cutler include:

  • "Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study" (2021), published in Blood

Cutler has also frequently collaborated with other researchers, notably:

  • Robert J. Soiffer
  • Joseph H. Antin
  • Mahasweta Gooptu
  • John Koreth
  • Sarah Nikiforow

The scope of their research focuses largely on hematologic diseases and transplantation therapies, reflected in the extensive body of work on chronic graft-versus-host disease, leukemia, and related immunologic and transplant outcomes. Their publication record since 2021 highlights ongoing involvement in clinical research concerning transplant complications and treatments.

Best Publications

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. Diagnosis and Staging Working Group Report

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease

    Madan H. Jagasia;Hildegard T. Greinix;Mukta Arora;Kirsten M. Williams

  • Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease

    John Koreth;Ken Ichi Matsuoka;Haesook T. Kim;Sean M. McDonough

  • Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.

    John Koreth;Richard Schlenk;Kenneth J. Kopecky;Sumihisa Honda

  • Peripheral-Blood Stem Cells versus Bone Marrow from Unrelated Donors

    Claudio Anasetti;Brent R. Logan;Stephanie J. Lee;Edmund K. Waller

  • A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome

    Corey S. Cutler;Stephanie J. Lee;Peter Greenberg;H. Joachim Deeg

  • Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.

    R Coleman Lindsley;Wael Saber;Brenton G Mar;Robert Redd

  • Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts

    Claudio G. Brunstein;Ephraim J. Fuchs;Shelly L. Carter;Chatchada Karanes

  • Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

    Madan Jagasia;Mukta Arora;Mary E D Flowers;Nelson J. Chao

  • First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation.

    Paul J. Martin;J. Douglas Rizzo;John R. Wingard;Karen Ballen

  • Ipilimumab for Patients with Relapse after Allogeneic Transplantation

    Matthew S. Davids;Haesook T. Kim;Pavan Bachireddy;Caitlin Costello

  • Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: an individual patient data meta-analysis of nine randomized trials

    Mahmoud al-Jurf;Mahmoud al-Jurf;Francisco Aranha;Francisco Aranha;Claudio Annasetti;Jane F. Apperley;Jane F. Apperley

  • Acute and Chronic Graft-Versus-Host Disease After Allogeneic Peripheral-Blood Stem-Cell and Bone Marrow Transplantation: A Meta-Analysis

    Corey Cutler;Satyendra Giri;Suriya Jeyapalan;David Paniagua

  • Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission

    David B. Miklos;David B. Miklos;Haesook T. Kim;Haesook T. Kim;Katherine H. Miller;Katherine H. Miller;Luxuan Guo;Luxuan Guo

  • Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation

    Philippe Armand;Haesook T. Kim;Corey S. Cutler;Vincent T. Ho

  • Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease

    Ken-ichi Matsuoka;John Koreth;Haesook T. Kim;O. Gregory Bascug

  • Rituximab for steroid-refractory chronic graft-versus-host disease.

    Corey Cutler;David Miklos;Haesook T. Kim;Nathaniel Treister

  • Blood and Marrow Transplant Clinical Trials Network Toxicity Committee consensus summary: Thrombotic microangiopathy after hematopoietic stem cell transplantation

    Vincent T. Ho;Corey Cutler;Shelly Carter;Paul Martin

  • Somatic Mutations Predict Poor Outcome in Patients With Myelodysplastic Syndrome After Hematopoietic Stem-Cell Transplantation

    Rafael Bejar;Kristen E. Stevenson;Bennett Caughey;R. Coleman Lindsley

  • Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

    Joseph Pidala;Brenda Kurland;Xiaoyu Chai;Navneet S. Majhail

Frequent Co-Authors

Joseph H. Antin
Joseph H. Antin Dana-Farber Cancer Institute
Robert J. Soiffer
Robert J. Soiffer Harvard University
Vincent T. Ho
Vincent T. Ho Harvard University
Edwin P. Alyea
Edwin P. Alyea Harvard University
John Koreth
John Koreth Harvard University
Haesook T. Kim
Haesook T. Kim Harvard University
Jerome Ritz
Jerome Ritz Harvard University
Philippe Armand
Philippe Armand Harvard University
Stephanie J. Lee
Stephanie J. Lee Fred Hutchinson Cancer Research Center
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in the healthcare field but looking for alternatives to traditional medical school, there are several flexible online degrees and career pathways to consider. Many students pursue nursing as a rewarding and versatile healthcare career. If you already hold a non-nursing bachelor's degree, you might explore the cheapest direct entry msn programs that offer accelerated options to earn a Master of Science in Nursing.

Alternatively, online adn programs provide a practical entry point to becoming a registered nurse without the time commitment of a traditional four-year degree. For prospective students seeking an easier admissions process, some schools are highlighted as a nursing school that doesn't require teas exam, making the path to a nursing career more accessible.

Beyond patient care roles, there are in-demand non-clinical healthcare careers as well. Earning a credential through reputable medical billing and coding schools online can open opportunities in healthcare administration. These programs are often flexible and come with financial aid options, enabling faster entry into the workforce.

Best Scientists Citing Corey Cutler

Trending Scientists

Recently Published Articles